As of 2025-08-05, the Relative Valuation of Arch Biopartners Inc (ARCH.V) is (1.19) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.75 CAD, the upside of Arch Biopartners Inc based on Relative Valuation is -167.9%.
The range of the Relative Valuation is (1.21) - (1.24) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.4x - 31.5x | 29.7x |
| Forward P/E multiples | 18.5x - 27.0x | 22.2x |
| Fair Price | (1.21) - (1.24) | (1.19) |
| Upside | -169.2% - -170.7% | -167.9% |
| Date | P/E |
| 2025-08-01 | -38.19 |
| 2025-07-31 | -36.88 |
| 2025-07-30 | -35.79 |
| 2025-07-29 | -36.45 |
| 2025-07-28 | -36.45 |
| 2025-07-25 | -35.79 |
| 2025-07-24 | -36.01 |
| 2025-07-23 | -37.97 |
| 2025-07-22 | -38.19 |
| 2025-07-21 | -38.19 |
| 2025-07-18 | -37.76 |
| 2025-07-17 | -38.19 |
| 2025-07-16 | -37.54 |
| 2025-07-15 | -37.76 |
| 2025-07-14 | -37.76 |
| 2025-07-11 | -37.54 |
| 2025-07-10 | -37.32 |
| 2025-07-09 | -36.88 |
| 2025-07-08 | -37.10 |
| 2025-07-07 | -37.54 |
| 2025-07-04 | -38.19 |
| 2025-07-03 | -41.47 |
| 2025-07-02 | -38.85 |
| 2025-06-30 | -39.28 |
| 2025-06-27 | -41.03 |
| 2025-06-26 | -40.81 |
| 2025-06-25 | -41.68 |
| 2025-06-24 | -38.85 |
| 2025-06-23 | -37.32 |
| 2025-06-20 | -37.97 |
| 2025-06-19 | -37.76 |
| 2025-06-18 | -37.54 |
| 2025-06-17 | -38.41 |
| 2025-06-16 | -40.38 |
| 2025-06-13 | -40.59 |
| 2025-06-12 | -40.59 |
| 2025-06-11 | -40.38 |
| 2025-06-10 | -40.59 |
| 2025-06-09 | -40.81 |
| 2025-06-06 | -40.59 |
| 2025-06-05 | -39.72 |
| 2025-06-04 | -39.50 |
| 2025-06-03 | -39.94 |
| 2025-06-02 | -39.28 |
| 2025-05-30 | -38.85 |
| 2025-05-29 | -38.63 |
| 2025-05-28 | -39.72 |
| 2025-05-27 | -38.19 |
| 2025-05-26 | -38.19 |
| 2025-05-23 | -38.19 |